Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Measuring biological activity during compound accumulation in Escherichia coli using time-course gene expression profiles

EF 2020-21

Résumé
Multidrug-resistant Gram-negative bacteria are a cause of infections worldwide and have few effective treatment options. In Gram-negative bacteria, the presence of the outer membrane (OM) is a barrier to antibiotic activity. The OM is a selectively permeably, complex lipid bilayer of polysaccharides, phospholipids, and proteins that reduces access to intracellular antibiotic targets. By exploring the biological responses to intracellular accumulation of antibacterial compounds we can identify unique compound-target interactions and resistance mechanisms of the cell crucial for developing novel treatment strategies. The OM barrier of Gram-negative bacteria limits our available knowledge of biological responses to only the antibacterial compounds that can bypass the membrane. The goal of this research project is to explore the cellular response phenotypes of Gram-negative bacteria to compounds that are limited by the membrane. Using a fluorescent reporter genetic library of the Gram-negative bacterium, Escherichia coli, and a unique fluorescence imaging platform we can collect promoter expression phenotypes to a variety of antibacterial compounds. Disruption of the OM with a known OM perturbant will facilitate compound entry into the cell and we can report on the transcriptional responses to a variety of chemical probes that are traditionally inactive in E. coli. These responses will be used to inform on susceptible genetic pathways for combination therapy and the novel treatment of Gram-negative bacteria.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
449464
Name
Zary Miranda
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Measuring biological activity during compound accumulation in Escherichia coli using time-course gene expression profiles
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibiotic Resistance; Cell Biology; Compound Accumulation; Gene Expression; Gram-Negative Bacteria; Infectious Disease; Outer Membrane; Stress Responses
Abstract
Multidrug-resistant Gram-negative bacteria are a cause of infections worldwide and have few effective treatment options. In Gram-negative bacteria, the presence of the outer membrane (OM) is a barrier to antibiotic activity. The OM is a selectively permeably, complex lipid bilayer of polysaccharides, phospholipids, and proteins that reduces access to intracellular antibiotic targets. By exploring the biological responses to intracellular accumulation of antibacterial compounds we can identify unique compound-target interactions and resistance mechanisms of the cell crucial for developing novel treatment strategies. The OM barrier of Gram-negative bacteria limits our available knowledge of biological responses to only the antibacterial compounds that can bypass the membrane. The goal of this research project is to explore the cellular response phenotypes of Gram-negative bacteria to compounds that are limited by the membrane. Using a fluorescent reporter genetic library of the Gram-negative bacterium, Escherichia coli, and a unique fluorescence imaging platform we can collect promoter expression phenotypes to a variety of antibacterial compounds. Disruption of the OM with a known OM perturbant will facilitate compound entry into the cell and we can report on the transcriptional responses to a variety of chemical probes that are traditionally inactive in E. coli. These responses will be used to inform on susceptible genetic pathways for combination therapy and the novel treatment of Gram-negative bacteria.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zary, Miranda
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~